70.27
+1.72(+2.51%)
Currency In USD
| Previous Close | 68.55 |
| Open | 69.12 |
| Day High | 70.3 |
| Day Low | 68.8 |
| 52-Week High | 74.43 |
| 52-Week Low | 46.86 |
| Volume | 59,665 |
| Average Volume | 51,601 |
| Market Cap | 893.83M |
| PE | 43.65 |
| EPS | 1.61 |
| Moving Average 50 Days | 68.25 |
| Moving Average 200 Days | 58.79 |
| Change | 1.72 |
If you invested $1000 in IRadimed Corporation (IRMD) 10 years ago, it would be worth $3,169.6 as of September 28, 2025 at a share price of $70.27. Whereas If you bought $1000 worth of IRadimed Corporation (IRMD) shares 5 years ago, it would be worth $3,599.9 as of September 28, 2025 at a share price of $70.27.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
IRADIMED CORPORATION to Participate in the 2025 Wells Fargo Healthcare Conference
GlobeNewswire Inc.
Aug 26, 2025 8:05 PM GMT
ORLANDO, Fla., Aug. 26, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), a leader in innovative medical devices for Magnetic Resonance Imaging (“MRI”) compatible patient monitoring and infusion systems, today announced that it will par
IRADIMED CORPORATION to Hold Second Quarter of 2025 Financial Results Conference Call on August 1, 2025
GlobeNewswire Inc.
Jul 25, 2025 8:05 PM GMT
ORLANDO, Fla., July 25, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2025 second quarter financial results before the market opens on Friday, August 1, 2025. Iradimed management will
IRADIMED CORPORATION Announces FDA 510(k) Clearance for MRidium® 3870 Infusion Pump System
GlobeNewswire Inc.
May 29, 2025 12:30 PM GMT
WINTER SPRINGS, Fla., May 29, 2025 (GLOBE NEWSWIRE) -- Iradimed Corporation (NASDAQ: IRMD), a global leader in innovative medical devices for MRI environments, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clea